Search
Selected Filter
Filter Results
Displaying 1–10 of 310 research results
-
Mar 27, 2024
Nanoscope Plans to Apply for FDA Approval for its Optogenetic Therapy
The company reported positive two-year results for its Phase 2 clinical trial of MCO-010.
-
Mar 26, 2024
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
The company plans to administer a higher dose of the emerging gene therapy to the next group of patients.
-
Feb 21, 2024
jCyte Announces Plans to Launch Phase 3 Clinical Trial of Cell Therapy for RP
Known as retinal progenitors, the company’s jCells® are designed to preserve photoreceptors in people with retinitis pigmentosa (RP) and other retinal diseases.
-
Feb 9, 2024
The company plans to begin a Phase 2/3 clinical trial for the treatment during the first half of 2024.
-
Feb 1, 2024
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.
-
Jan 8, 2024
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Jan 8, 2024
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Jan 8, 2024
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Jan 8, 2024
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Jan 8, 2024
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.